We believe the novelty of our study is that we performed a comprehensive analysis by using both functional assays and transcriptomic analysis, which allowed us to pinpoint a mechanism whereby BET inhibition affects intracellular calcium (Ca2+) and related signaling in SSc fibroblasts. The gene discussed is DNER; the disease is systemic sclerosis.